PECAM1 and neoplasm: To assess the relationship between tumor angiogenesis markers and survival, a panel of immunohistochemical factors was used—VEGF, thrombospondin-1 (TSP-1, antiangiogenesis factor), CD31 (a nonspecific endothelial marker), and CD105 (a tumor-specific endothelial marker) [68].